3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Conditions
Sarcoma
190
Osteosarcoma
73
Sarcoma, Ewing
50
Rhabdomyosarcoma
45
Melanoma
40
Neuroblastoma
36
Gastrointestinal Stromal Tumors
35
Neoplasms
33
Colorectal Neoplasms
29
Bone Neoplasms
29
Glioblastoma
28
Neoplasm Metastasis
27
Ovarian Neoplasms
25
Breast Neoplasms
25
Wilms Tumor
22
Gliosarcoma
22
Glioma
22
Rhabdoid Tumor
21
Lymphoma, Non-Hodgkin
21
Sarcoma, Kaposi
20
Liposarcoma
20
Carcinoma, Non-Small-Cell Lung
20
Hepatoblastoma
19
Pancreatic Neoplasms
18
Neurofibrosarcoma
18
Medulloblastoma
18
Carcinoma, Renal Cell
18
Lymphoma
17
Desmoid Tumors
17
Thyroid Neoplasms
16
Interventions
relatlimab
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tertiary Lymphoid Structures
×
Sarcoma
×
90 days
×
Clear all
NCT04095208
2026-04-21
CONGRATS
Institut Bergonié
Phase 2
Completed
68 enrolled